
Returning European Vacationers In Their EVs Should Slow Down-Report
According to Geotab Inc, a telematics company headquartered in Ontario, Canada, EV drivers have much more to worry about from speed on a long-range trip than the heat.
Geotab, which describes itself as a global leader in connected vehicle solutions, said in a report 'Summer heat vs speed: what really impacts EV range?' that hot weather does have an effect, but driving speed can be the single biggest factor in range loss.
Europe has an extensive autoroute system allowing cruising speeds of around 80 mph or more for hours on end. The limit on most autoroutes is 130 km/h or 81 mph. Germany's autoroutes have sections without speed limits, although most powerful cars limit speeds to 150 mph. The trouble with EVs is that although they can match or exceed internal combustion engines over a range of tasks, when speeds reach 60 mph range begins to be seriously diminished. Up to 50% of range can be wiped away at these higher speeds, according to WintonsWorld.com data.
'At higher speeds of between 50 and 80 mph in hot temperatures (30C to 86F), driving speed can be the single biggest factor in range loss,' the report said.
'The data shows that even modest increases in speed leads to steep range losses. For example, a 65-kWh electric van cruising at 50 mph in 86 °F heat with the air conditioning on has a typical range of around 143 miles. Increase that speed to 60 mph, and range drops to 121 miles. At 70 mph it falls further to 103 miles, and by 80 mph, you're down to just 88 miles. That's a 39% drop in range between 50 and 80 mph,' according to the report.
'The pattern is similar for electric sedans, though they're slightly more aerodynamic. At 50 mph at 86°F, you can expect 277 miles. At 60 mph: 251 miles. At 70 mph: 226 miles. And at 80 mph: 200 miles - a 28% drop from the most efficient cruising speed.
The report said this sharp decline comes down to physics. The faster the speed the more the car has to fight air resistance. Aerodynamic drag increases with the square of the speed, so doubling speed requires four times the energy just to overcome wind resistance. That's far more than the air conditioning system will ever use.
'Drivers tend to worry about using the aircon in hot weather, but our data shows that your right foot can make the biggest difference, particularly at high speeds," said Charlotte Argue, Senior Manager, Sustainability, at Geotab.
'Just slowing down by 10 or 15 mph can extend your range by 20–30%, depending on the vehicle,' she said.
Peter Wells, Professor of Business Sustainability at Cardiff Business School has summed up the problem like this.
'Range falls off a cliff at high speed. For an electric car, the extra energy required getting from 60 mph to 75 mph is astonishing and virtually doubles energy consumption to move all that air out of the way,' according to Wells.
Emissions Analytics CEO Nick Molden has explained the problem this way.
'Air resistance (drag force) is proportional to the square of the speed. Drag will correlate (negatively) with range. So range will decline more than proportionately as speed increases. Vehicle design can change other factors, such as the coefficient of drag (Cd), which is why Tesla has focused so much on aerodynamics,' Molden said.
'All other things being equal, the drag force will be 164% higher at 130 km/h than at 80 km/h (50 mph) which is a speed increase of 63%,' Molden said.
As Europeans and their families return home at the end of August, there are often gigantic traffic jams stretching for miles. Perhaps the frustration this time will be mitigated slightly as EV owners feel a bit smug about eliminating range anxiety.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Associated Press
27 minutes ago
- Associated Press
Dr. Nikola Cihoric Redefines Clinical Research Through Innovation, Technology, and Data
ZURICH, SWITZERLAND, August 21, 2025 / / -- Bridging Medicine, Research, and Technology for Patient-Centric Solutions Dr. Nikola Cihoric, founder and visionary behind Wemedoo AG, is redefining clinical research by merging technology, innovation, medicine, and data into a seamless ecosystem that empowers healthcare professionals and researchers alike. With over 15 years of experience in radiation oncology and a deep commitment to clinical data standardization, Dr. Cihoric is setting a new standard in the way clinical trials are conducted worldwide. A Vision Born from Real Clinical Challenges Wemedoo was born from Dr. Cihoric's firsthand frustration with fragmented healthcare systems and inefficient clinical workflows. 'I observed the paper world and sloppy digitalization that slowed treatment delivery and overburdened medical staff,' he explains. His focus on data standardization and cross-sector collaboration led to the development of an early prototype, oopus (initially SmartOncology), which received support from the Swiss Cancer Foundation. Building on this experience, Wemedoo developed its unique approach, which eliminates silos, enhances transparency, and gives researchers full control across the clinical data lifecycle. Learn more about Dr. Cihoric's vision in the Xraised interview. Transforming Clinical Trials Through Technology Unlike traditional clinical trial solutions that rely on multiple disconnected systems, Wemedoo's oomnia system integrates EDC, CTMS, eTMF, eConsent, RTSM, and advanced reporting in a single, unified, and interoperable environment. This approach eliminates costly integrations, reduces errors, and ensures data consistency across every stage of a trial. 'By using technology to unify processes, we save time, reduce errors, and provide real-time insights for clinicians and researchers,' Dr. Cihoric notes. 'Our no-code configuration also allows rapid adaptation to evolving trial requirements, ensuring flexibility without compromising quality.' Ethical AI and Data-Driven Innovation Wemedoo integrates AI into oomnia practically and responsibly, focusing on automating processes where it delivers immediate value without unnecessary risks, essential in a highly regulated industry. Their work is guided by explainability and transparency, from AI-driven risk assessment tools for protocol design to semantic mapping engines that cut data processing timelines from months to days. Wemedoo is also exploring agentic AI to support operational decision-making, always with a 'man-in-control' philosophy to ensure accountability. What makes this possible is oomnia's semantic foundation, structured data, common data elements, and standard vocabularies, which keep outcomes reproducible, interpretable, and aligned with regulatory frameworks. Beyond technology, Wemedoo collaborates with public institutions and publish in peer-reviewed journals, reinforcing their belief that AI is only meaningful if it strengthens trust, transparency, and data integrity. Balancing Clinical Practice and Product Development Despite his active role at Wemedoo, Dr. Cihoric continues to work in a leading academic hospital. This dual role allows him to translate real-world clinical challenges into actionable system improvements. 'Being close to patients and clinical teams keeps me grounded in reality, ensuring that our technology delivers tangible benefits,' he says. Long-Term Vision for Clinical Research Looking ahead, Dr. Cihoric aims to remove barriers between clinical practice and research, investing in education, resources, and stakeholder alignment to ultimately improve patient outcomes. 'The goal is to create a future where innovation, technology, and real-world data converge seamlessly to benefit patients worldwide,' he asserts. About Dr. Nikola Cihoric Dr. Nikola Cihoric is a radiation oncologist, researcher, and founder of Wemedoo AG, with expertise in clinical data standardization, AI integration, and oncology innovation. He has published over 35 scientific papers and actively contributed to international standards groups such as mCODE, CodeX, HL7/FHIR, and CDISC. For more information on Dr. Nikola Cihoric and Wemedoo's groundbreaking work, visit Wemedoo and explore insights from Xraised ( ). Media and Business Inquiries General contact: [email protected] Business development: [email protected] Website: LinkedIn: Wemedoo AG. Gianmarco Giordaniello Xraised email us here Visit us on social media: LinkedIn Instagram X Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Bloomberg
27 minutes ago
- Bloomberg
US and EU Take Steps to Formalize Trade Deal
Details of a trade pact between the US and EU have been released, with a joint statement issued today saying that tariffs on European cars could be cut within weeks, with the potential for reductions on other goods, too. After a preliminary deal announced a month ago, the statement lists specific benchmarks for the EU to get sector-specific discounts on cars, drugs and semiconductors. It also details new commitments to cooperate on standards for food, as well as economic security and digital trade.
Yahoo
31 minutes ago
- Yahoo
Aleix Espargaro out of MotoGP Hungarian GP after another bicycle crash
Aleix Espargaro will not ride the LCR Honda at this weekend's Hungarian Grand Prix following another cycling injury for the Spaniard ahead of the race at Balaton Park. Espargaro's withdrawal is the latest development in a four-race saga around the #35 entry. It's a story that has been running ever since the bike's regular rider, Somkiat Chantra, injured himself in a training accident ahead of the German Grand Prix last month. While the team's lead rider, Johann Zarco, flew the flag alone in Austria last weekend, the Frenchman had expected HRC test rider Espargaro to join him in Hungary. But yet another bicycle injury for the budding professional cyclist has put paid to that plan. 'Unfortunately, Aleix suffered a cycling accident a few days ago,' read a statement from the team. 'While it initially seemed minor, he arrived at the track on Thursday morning with severe back pain. Somkiat Chantra, Team LCR Honda 'Medical examinations have revealed that his L3 vertebra is affected. He is now returning to Barcelona to undergo further tests at Hospital Universitari Dexeus.' Chantra, meanwhile, is targeting a return to his bike for the next round of the championship in Spain. After working on his recovery in Thailand, Chantra is back in Barcelona and has intensified his rehabilitation with the aim of returning at the Catalan Grand Prix, set for the first weekend of September in Barcelona. 'Somkiat rested for two weeks in his home country, but he hasn't stopped working on his recovery from his injury,' LCR team owner Lucio Cecchinello told on Thursday. Chantra is almost certain to lose his spot on the MotoGP grid next season following the news that Moto2 start Diogo Moreira will race for LCR in 2026. Read Also: Honda in conundrum over Somkiat Chantra stand-in for MotoGP Austrian GP Aleix Espargaro 'more like a cyclist than a MotoGP rider' ahead of Spanish GP wildcard To read more articles visit our website.